A Functional Polymorphism in the COMT Gene and Performance on a Test of Prefrontal Cognition
Top Cited Papers
- 1 April 2002
- journal article
- research article
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 159 (4) , 652-654
- https://doi.org/10.1176/appi.ajp.159.4.652
Abstract
OBJECTIVE: In the prefrontal cortex, the enzyme catechol O-methyltransferase (COMT) is critical in the metabolic degradation of dopamine, a neurotransmitter hypothesized to influence human cognitive function. The COMT gene contains a functional polymorphism, Val158Met, that exerts a fourfold effect on enzyme activity. The current study investigated whether prefrontal cognition varies with COMT genotype. METHOD: Val158Met was genotyped in 73 healthy volunteers. A task of prefrontal cognition, the Wisconsin Card Sorting Test, was also administered. RESULTS: Subjects with only the low-activity met allele made significantly fewer perseverative errors on the Wisconsin Card Sorting Test than did subjects with the val allele. CONCLUSIONS: These data are consistent with those of previous studies, suggesting that a functional genetic polymorphism may influence prefrontal cognition.Keywords
This publication has 9 references indexed in Scilit:
- Effect of COMT Val 108/158 Met genotype on frontal lobe function and risk for schizophreniaProceedings of the National Academy of Sciences, 2001
- Family-based linkage disequilibrium mapping using SNP marker haplotypes: application to a potential locus for schizophrenia at chromosome 22q11Molecular Psychiatry, 2000
- Cognition and control in schizophrenia: a computational model of dopamine and prefrontal functionBiological Psychiatry, 1999
- Use of Unlinked Genetic Markers to Detect Population Stratification in Association StudiesAmerican Journal of Human Genetics, 1999
- Subchronic Phencyclidine Administration Reduces Mesoprefrontal Dopamine Utilization and Impairs Prefrontal Cortical-Dependent Cognition in the RatNeuropsychopharmacology, 1997
- Cognitive improvement during Tolcapone treatment in Parkinson's diseaseJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1997
- Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disordersPharmacogenetics, 1996
- 3‐Methoxytyramine Is the Major Metabolite of Released Dopamine in the Rat Frontal Cortex: Reassessment of the Effects of Antipsychotics on the Dynamics of Dopamine Release and Metabolism in the Frontal Cortex, Nucleus Accumbens, and Striatum by a Simple Two Pool ModelJournal of Neurochemistry, 1994
- ON THE COMPARISON OF SEVERAL MEAN VALUES: AN ALTERNATIVE APPROACHBiometrika, 1951